Search results
Showing 1921 to 1935 of 2580 results for methods
Ublituximab with ibrutinib for previously treated chronic lymphocytic leukaemia [ID1476]
Discontinued Reference number: GID-TA10447
Baricitinib for treating active autoantibody-positive systemic lupus erythematosus [ID3997]
Discontinued Reference number: GID-TA10892
Discontinued Reference number: GID-TA10811
Nitazoxanide for treating the common cold in people 12 years and over [ID4049]
In development Reference number: GID-TA11128 Expected publication date: TBC
Breast cancer (metastatic) -trastuzumab (as monotherapy and in combination with a taxane) [ID345]
Discontinued Reference number: GID-TAG417
Discontinued Reference number: GID-TA10525
Magrolimab with azacitidine for untreated myelodysplastic syndromes [ID3978]
Discontinued Reference number: GID-TA10861
Discontinued Reference number: GID-TA10159
Iclepertin for treating cognitive impairment associated with schizophrenia [ID6483]
In development Reference number: GID-TA11647 Expected publication date: TBC
Discontinued Reference number: GID-TA11655
In development Reference number: GID-TA11808 Expected publication date: TBC
Pembrolizumab with epacadostat for untreated malignant melanoma [ID1423]
Discontinued Reference number: GID-TA10330
In development Reference number: GID-TA11645 Expected publication date: TBC
In development Reference number: GID-TA11581 Expected publication date: TBC
In development Reference number: GID-TA11654 Expected publication date: TBC